16199-99-8 Usage
Description
1-Allyl-5-oxo-pyrrolidine-3-carboxylic acid is a chemical compound that belongs to the class of L-pyroglutamic acids, which are amino acids containing pyroglutamic acid. It has a chemical formula of C8H11NO3 and exhibits acidic properties due to the presence of the carboxyl group (-COOH). The allyl group attached to the molecule suggests that it may undergo reactions typical of alkenes, such as addition reactions. Due to the limited information available, its toxicity and potential hazards are not well-known, and it is important to handle this chemical with appropriate safety protocols.
Uses
1. Used in Chemical Synthesis:
1-Allyl-5-oxo-pyrrolidine-3-carboxylic acid is used as a building block in the synthesis of various chemical compounds. Its unique structure, including the pyrrolidine-3-carboxylic acid group and the allyl group, allows for the creation of a wide range of molecules with potential applications in different industries.
2. Used in Pharmaceutical Research:
1-Allyl-5-oxo-pyrrolidine-3-carboxylic acid is used as a research compound in the development of new pharmaceuticals. Its acidic properties and the presence of the allyl group may contribute to the design of novel drug molecules with potential therapeutic applications.
3. Used in Material Science:
1-Allyl-5-oxo-pyrrolidine-3-carboxylic acid is used as a component in the development of new materials with specific properties. The reactivity of the allyl group may enable the creation of materials with unique characteristics, such as improved strength or flexibility.
4. Used in Analytical Chemistry:
1-Allyl-5-oxo-pyrrolidine-3-carboxylic acid is used as a reference compound in analytical chemistry for the identification and quantification of similar compounds. Its distinct structure and properties make it a valuable tool in the analysis of complex mixtures.
5. Used in Environmental Applications:
1-Allyl-5-oxo-pyrrolidine-3-carboxylic acid may be used in environmental applications, such as the remediation of contaminated sites or the development of eco-friendly materials. Its chemical properties could potentially be harnessed to improve the efficiency of these processes.
Check Digit Verification of cas no
The CAS Registry Mumber 16199-99-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,1,9 and 9 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 16199-99:
(7*1)+(6*6)+(5*1)+(4*9)+(3*9)+(2*9)+(1*9)=138
138 % 10 = 8
So 16199-99-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H11NO3/c1-2-3-9-5-6(8(11)12)4-7(9)10/h2,6H,1,3-5H2,(H,11,12)
16199-99-8Relevant articles and documents
PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS
-
Page/Page column 42, (2016/06/01)
Simple organic structures, organic/inorganic polymers, and other substrates have been made, all of which have at least one pyrrolidone moiety present, and found to exhibit low toxicity, low complement activation features and may be used to reduce protein
CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT
-
Page/Page column 31, (2008/06/13)
Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is formula (I) X is -0-, -C(R14)2- or -N(R)-; Z is -C(R14)2- or -N(R)-; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, -CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, -OR35, -N(R24)(R25)or -SR35; R41 is alkyl, cycloalkyl, -S02(alkyl), -C(O)-alkyl, -C(O)-cycloalkyl or -alkyl-NH-C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula (I). Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.
